Considerable efforts have been made to diminish tau aggregation in AD, including stabilizing microtubules, inhibiting tau phosphorylation or acetylation, reducing tau expression, or inhibiting fibrilization4. This evidence concerns the gene MAPT and Alzheimer disease.